Zoekresultaten - 39 results
The European response to the WHO call cervical cancer as a public health problem
achieve 70% of screening coverage in the target age group, providing also HPV testing on self‐samples for non‐ or under‐screened women; and to manage 90% of screen‐positive women. To guide member states, ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
powerful tools are available for primary and secondary prevention of cervical cancer, among which prophylactic HPV vaccines, and screening using validated HPV tests for women—including some tests that can be ...
Algorithms for molecular testing in solid tumours
Bulcke; P Pauwels Source: Belgian Journal of Medical Oncology (BJMO, Volume 13, Issue 7, Number 295 (2019) Abstract: In order to advise the Federal Government on the reimbursement of molecular tests related ...
Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the commission personalised medicine
Publication Type: Peer reviewed scientific article Authors: Els Van Valckenborgh; E Boone; A Camboni; JP Defour; B Denys; H Devos; L Dewispelaere; Guy Froyen; Aline Hébrant; P Heimann; P Hermans; E Heylen; K Jacobs; F Lambert; Marie Le Mercier; Els Lierma ...
Molecular test algorithms for breast tumours
13, Issue 2, Number 45 (2019) Abstract: In order to advise the Federal Government on all matters related to personalised medicine in oncology, including the reimbursement of molecular tests, the ...
Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.
review was performed to identify studies in which at least 50 healthy individuals were tested for oral HPV infection. Information on sex, age, tobacco/alcohol consumption, sex practices, specimen ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
can be triaged accurately with a high-risk human papillomavirus (hrHPV) test to identify those who need a referral. However, the triage of low-grade squamous intraepithelial lesion (LSIL) with hrHPV ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
repeat invitation letters or an HPV self-collection kit. Colposcopy should be carried out for further investigation if cytology findings are Pap II-p and HPV test results are positive or if the results of ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
HPV-based screening. Co-testing can also be carried out. Women between the ages of 20 and 35 should have cytological screening every 2 years. Health Topics: Quality of healthcare Cancer Qualité des soins de ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2 ...